Introduction {#s1}
============

The prevalence of obesity is increasing globally. Obesity impacts whole-body homeostasis and is a risk factor for severe health complications including type 2 diabetes and cardiovascular disease. Accumulating epidemiological evidence indicates that obesity also leads to elevated risk of developing several types of cancers ([@bib3]; [@bib26]; [@bib1]). However, the mechanisms that link obesity and cancer remain incompletely understood. Using *Drosophila*, we recently developed a whole-animal model system to study the link between diet-induced obesity and cancer and provided a potential explanation for how obese and insulin resistant animals are at increased risk for tumor progression ([@bib15]).

*Drosophila* fed a diet containing high levels of sucrose (high dietary sucrose or 'HDS') developed sugar-dependent metabolic defects including accumulation of fat (obesity), organismal insulin resistance, hyperglycemia, hyperinsulinemia, heart defects and liver (fat body) dysfunctions ([@bib18], [@bib19]; [@bib20]; [@bib21]). Inducing activation of oncogenic Ras and Src together in the *Drosophila* eye epithelia led to development of small benign tumors within the eye epithelia. Feeding animals HDS transformed Ras/Src-activated cells from benign tumor growths to aggressive tumor overgrowth with tumors spread into other regions of the body ([@bib15]). While most tissues of animals fed HDS displayed insulin resistance, Ras/Src-activated tumors retained insulin pathway sensitivity and exhibited an increased ability to import glucose. This is reflected by increased expression of the Insulin Receptor (InR), which was activated through an increase in canonical Wingless (Wg)/dWnt signaling that resulted in evasion of diet-mediated insulin resistance in Ras/Src-activated cells. Conversely, expressing a constitutively active isoform of the Insulin Receptor in Ras/Src-activated cells (InR/Ras/Src) was sufficient to elevate Wg signaling, promoting tumor overgrowth in animals fed a control diet. These results revealed a circuit with a feed-forward mechanism that directs elevated Wg signaling and InR expression specifically in Ras/Src-activated cells. Through this circuit, mitogenic effects of insulin are not only preserved but are enhanced in Ras/Src-activated cells in the presence of organismal insulin resistance.

These studies provide an outline for a new mechanism by which tumors evade insulin resistance, but several questions remain: (i) how Ras/Src-activated cells sense the organism\'s increased insulin levels, (ii) how nutrient availability is converted into growth signals, and (iii) the trigger for increased Wg protein levels, a key mediator that promotes evasion of insulin resistance and enhanced Ras/Src-tumorigenesis consequent to HDS. In this manuscript, we identify the Hippo pathway effector Yorkie (Yki) as a primary source of increased Wg expression in diet-enhanced Ras/Src-tumors. We demonstrate that Ras/Src-activated cells are sensitized to Hippo signaling, and even a mild perturbation in upstream Hippo pathway is sufficient to dominantly promote Ras/Src-tumor growth. We provide functional evidence that increased insulin signaling promotes Salt-inducible kinases (SIKs) activity in Ras/Src-activated cells, revealing a SIKs-Yki-Wg axis as a key mediator of diet-enhanced Ras/Src-tumorigenesis. Through this pathway, Hippo-sensitized Ras/Src-activated cells are positioned to efficiently respond to insulin signals and promote tumor overgrowth. These mechanisms act as a feed-forward cassette that promotes tumor progression in dietary rich conditions, evading an otherwise insulin resistant state.

Results {#s2}
=======

Yorkie mediates increased Wg expression in diet-enhanced Ras/Src-tumors {#s2-1}
-----------------------------------------------------------------------

Ras/Src tumors were generated in the developing *Drosophila* eye epithelium by pairing targeted expression of the activated *dRas1* isoform *ras1*^*G12V*^ with targeted knockout ([@bib17]) of the negative regulator of Src, C-terminal src kinase (*csk^−/−^*). Feeding animals a diet containing 1.0 M sucrose (high dietary sucrose or 'HDS') transformed these Ras/Src-activated cells from benign growths to aggressive tumors associated with emergent tumor spread to other parts of the body ([Figure 1A,B](#fig1){ref-type="fig"}) ([@bib15]). In HDS-fed animals, Ras/Src-activated cells promoted gene expression of InR through increased canonical Wg-dependent signaling, leading to increased insulin sensitivity in Ras/Src-activated cells in otherwise insulin resistant animals. Expression of a constitutive active isoform of Insulin Receptor (*inr*^*CA*^) in Ras/Src-activated cells (*inr* ^*CA*^*,ras1*^*G12V*^*;csk^−/−^*) was sufficient to promote elevation of Wg levels and tumor growth even in a control diet, establishing an InR-Wg-InR amplification circuit that promotes aggressive tumorigenesis ([Figure 1E](#fig1){ref-type="fig"}) ([@bib15]).10.7554/eLife.08501.003Figure 1.Yorkie Activity is Required for Increased Wg Expression in Diet-enhanced Ras/Src-tumors.(**A**--**G**) Developmental stage matched third instar larvae with the genotype, (**A**, **B**) *ras1*^*G12V*^;*csk^−/−^*, (**C**) *ras1*^*G12V*^*;csk^−/−^,wg*^*RNAi*^, (**D**) *ras1*^*G12V*^*;csk^−/−^,wts*, (**E**) *inr*^*CA*^*,ras1*^*G12V*^*;csk^−/−^*, (**F**) *inr*^*CA*^*,ras1*^*G12V*^*;csk^−/−^,wg*^*RNAi*^, and (**G**) *inr*^*CA*^*,ras1*^*G12V*^*;csk^−/−^,wts,* raised on indicated diets. Images were taken at the same magnification. Scale bar, 500 μm. (**A′**--**G′**) Matching dissected eye epithelial tissue stained with DAPI (red). Images were taken at the same magnification. Scale bar, 500 μm. (**H**) Percent pupariation of animals from indicated genotypes and diets. Column bars represent the mean of three independent experiments. Error bars denote s.e.m. Total *n* was 166, 431, 309, 291, 204, 200, and 251 from left to right. Asterisks indicate statistically significant difference (\*p \< 0.01 t-test). Numerical data are available in [Figure 1---source data 1](#SD1-data){ref-type="supplementary-material"}. (**I**--**L**) Wg staining (red) of eye tissue from (**I**) *ras1*^*G12V*^*;csk^−/−^*, (**J**) *ras1*^*G12V*^*;csk^−/−^,wts*, (**K**) *inr*^*CA*^*,ras1*^*G12V*^*;csk^−/−^*, and (**L**) *inr*^*CA*^*,ras1*^*G12V*^*;csk^−/−^,wts* animals raised on indicated diets. Scale bars, 50 μm.**DOI:** [http://dx.doi.org/10.7554/eLife.08501.003](10.7554/eLife.08501.003)10.7554/eLife.08501.004Figure 1---source data 1.Percent pupariation of animals from indicated genotypes and diets.**DOI:** [http://dx.doi.org/10.7554/eLife.08501.004](10.7554/eLife.08501.004)10.7554/eLife.08501.005Figure 1---figure supplement 1.Effect of reducing Wg or over-expressing Wts in the eye tissue.(**A**, **B**) Reducing Wg by RNAi (*wg*^*RNAi*^) did not affect normal eye tissue growth of the late third instar larvae. Developmental stage matched *wg*^*RNAi*^ third instar larvae raised on (**A**) control diet, and (**B**) HDS. (**C**, **D**) Over-expression of Warts kinase led to small clones. Developmental stage matched *wts* third instar larvae raised on (**C**) control diet, and (**D**) HDS. Images were taken at the same magnification. Scale bar, 500 μm. (**A′**--**D′**) Matching dissected eye epithelial tissue stained with DAPI (red). Images were taken at the same magnification. Scale bar, 500 μm.**DOI:** [http://dx.doi.org/10.7554/eLife.08501.005](10.7554/eLife.08501.005)10.7554/eLife.08501.006Figure 1---figure supplement 2.Yorkie target genes are upregulated in diet-enhanced Ras/Src-tumors.(**A**--**C**) Myc staining (red) of (**A**) *ras1*^*G12V*^*;csk^−/−^* in control diet, (**B**) *ras1*^*G12V*^*;csk^−/−^* in HDS, and (**C**) *inr*^*CA*^*,ras1*^*G12V*^*;csk^−/−^* in control diet. (**D**--**F**) Cyclin E staining (red) of (**D**) *ras1*^*G12V*^*;csk^−/−^* in control diet, (**E**) *ras1*^*G12V*^*;csk^−/−^* in HDS, and (**F**) *inr*^*CA*^*,ras1*^*G12V*^*;csk^−/−^* in control diet. Images were taken at the same magnification. Scale bar, 50 μm.**DOI:** [http://dx.doi.org/10.7554/eLife.08501.006](10.7554/eLife.08501.006)

Reducing Wg by RNAi (*wg*^*RNAi*^) did not affect normal eye tissue growth of the late third instar larvae ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}). However, reducing Wg in Ras/Src-activated cells (*ras1*^*G12V*^*;csk^−/−^,wg*^*RNAi*^) fed HDS or in InR/Ras/Src-activated cells (*inr* ^*CA*^*,ras1*^*G12V*^*;csk^−/−^,wg*^*RNAi*^) fed a control diet significantly suppressed tumor growth ([Figure 1C,F](#fig1){ref-type="fig"}). As a result, whereas only 35.9% of *ras1*^*G12V*^*;csk^−/−^* animals in HDS and 42.6% of *inr*^*CA*^*,ras1*^*G12V*^*;csk^−/−^* animals in control diet initiated pupariation, most *ras1*^*G12V*^*;csk^−/−^,wg*^*RNAi*^ animals and *inr*^*CA*^*,ras1*^*G12V*^*;csk^−/−^,wg*^*RNAi*^ animals successfully pupariated ([Figure 1H](#fig1){ref-type="fig"}). These observations identify Wg as an essential mediator of diet-enhanced Ras/Src-tumors or InR/Ras/Src-tumors. However, the factors that elevate Wg expression in diet- or InR-activated Ras/Src-tumors has not been identified.

The Hippo pathway is an evolutionarily conserved signaling pathway that regulates tissue growth and cell fate ([@bib14]; [@bib12]). The Hippo pathway regulates growth through the transcriptional co-activator Yki, a *Drosophila* homolog of mammalian YAP/TAZ ([@bib16]). The core pathway kinase effector Warts (Wts) phosphorylates Yki and inhibits its activity by sequestering Yki in the cytoplasm ([@bib8]; [@bib34]; [@bib23]). Conversely, loss of components in the core Hippo complex results in translocation of Yki into the nucleus where it regulates factors that promote proliferation and inhibit cell death ([@bib11]; [@bib32]; [@bib33]).

Yki activation has been previously associated with increased expression of Wg ([@bib4]). Inhibition of Yki activity by over-expressing Wts led to small clones ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}). Similarly, over-expression of Wts in Ras/Src-activated cells (*ras1*^*G12V*^*;csk^−/−^,wts*) fed HDS or in InR/Ras/Src-activated cells (*inr*^*CA*^*,ras1*^*G12V*^*;csk^−/−^,wts*) fed a control diet led to a strong suppression of tumor growth and animal lethality ([Figure 1D,G and H](#fig1){ref-type="fig"}). Importantly, increased Wg expression was lost in these clones, indicating that Yki is required for the increased Wg expression observed in diet- or InR-activated Ras/Src-tumors ([Figure 1I--L](#fig1){ref-type="fig"}).

Yorkie target genes are upregulated in diet-enhanced Ras/Src-tumors {#s2-2}
-------------------------------------------------------------------

Myc and cyclin E are well-established transcriptional targets of Yki in *Drosophila* ([@bib27]; [@bib28]; [@bib22]). Myc and cyclin E were strongly elevated in eye clones of *ras1*^*G12V*^*;csk^−/−^* animals fed HDS and in *inr*^*CA*^*,ras1*^*G12V*^*;csk^−/−^* animals fed a control diet ([Figure 1---figure supplement 2](#fig1s2){ref-type="fig"}) compared to controls. As previously reported, *diap1* gene expression---assessed by the Yki transcriptional reporter *diap1-lacZ*---was strongly increased in the *ras1*^*G12V*^*;csk^−/−^* clones of animals raised in HDS compared to animals fed a control diet (([@bib15]) [Figure 2A,B](#fig2){ref-type="fig"}). Upon closer examination, *diap1* gene expression was at most mildly increased in most *ras1*^*G12V*^*;csk^−/−^* clones in animals fed a control diet ([Figure 2A](#fig2){ref-type="fig"}, arrowheads). This increase in Yki activity was not sufficient to promote tumor overgrowth: *ras1*^*G12V*^*;csk^−/−^* clones of animals raised in a control diet were progressively eliminated from the tissue by apoptotic cell death ([@bib15]). Activation of insulin signaling pathway alone (*inr*^*CA*^) failed to elevate *diap1* expression in a control diet ([Figure 2C](#fig2){ref-type="fig"}). However, the triple combination (*inr* ^*CA*^*,ras1*^*G12V*^*;csk^−/−^*) led to strongly elevated *diap1* gene expression, including in animals fed a control diet ([Figure 2D](#fig2){ref-type="fig"}). These results indicate that activation of Yki is an emergent property of Ras and Src co-activation, and increased insulin signaling further promotes Yki activity in Ras/Src-activated cells.10.7554/eLife.08501.007Figure 2.Ras/Src-activated Cells are Sensitive to Perturbations in the Hippo Signaling.(**A**--**D**) β-galactosidase (β-gal) staining (red) of eye tissue from (**A**, **B**) *ras1*^*G12V*^*;csk^−/−^,diap1-lacZ*, (**C**) *inr*^*CA*^*;diap1-lacZ,* (**D**) *inr*^*CA*^*,ras1*^*G12V*^*;csk^−/−^,diap1-lacZ* animals raised on indicated diets. Scale bars, 50 μm. (**E**--**H**) Developmental stage matched third instar larvae raised on control diet with the genotype, (**E**) *ex*^*+/−*^, (**F**) *ras1*^*G12V*^*;csk^−/−^,* (**G**, **H**) *ex*^*+/−*^,*ras1*^*G12V*^*;csk^−/−^*. Images were taken at the same magnification. Scale bar, 500 μm. (**E′**--**H′**) Matching dissected eye epithelial tissue stained with DAPI (red). Images were taken at the same magnification. Scale bar, 500 μm. (**I**) Percent pupariation of animals from indicated genotypes. Column bars represent the mean of three independent experiments. Error bars denote s.e.m. Total *n* of 389, 238, and 206 from left to right. Asterisks indicate statistically significant difference (\*p \< 0.01 t-test). Numerical data are available in [Figure 2---source data 1](#SD2-data){ref-type="supplementary-material"} (**J**) β-galactosidase (β-gal) staining (red) of *ex*^*+/−*^, *ras1*^*G12V*^*;csk^−/−^* animals raised on control diet. Scale bar, 50 μm.**DOI:** [http://dx.doi.org/10.7554/eLife.08501.007](10.7554/eLife.08501.007)10.7554/eLife.08501.008Figure 2---source data 1.Percent pupariation of animals from indicated genotypes.**DOI:** [http://dx.doi.org/10.7554/eLife.08501.008](10.7554/eLife.08501.008)

Ras/src-activated cells are sensitized to upstream Hippo signals {#s2-3}
----------------------------------------------------------------

The FERM domain protein Expanded (Ex) is both an upstream regulator of the Hippo pathway and a transcriptional target of Yki, forming a negative feedback loop ([@bib13]). An enhancer trap fly line in which a *lacZ* gene is inserted in the *ex* locus (*ex*^*674*^; \[[@bib2]\]) can therefore be used to reduce *ex* activity as well as a readout of Yki transcriptional activity. Removing a functional genomic copy of *ex* (*ex*^*+/−*^) did not affect normal eye tissue growth ([Figure 2E](#fig2){ref-type="fig"}). Surprisingly, reducing *ex* in *ras1*^*G12V*^*;csk^−/−^* animals (*ex*^*+/−*^*,ras1*^*G12V*^*;csk^−/−^*) dominantly promoted growth of Ras/Src-activated cells in a control diet ([Figure 2F-H](#fig2){ref-type="fig"}). As a consequence, 40% of *ex*^*+/−*^,*ras1*^*G12V*^*;csk^−/−^* animals in control diet failed to initiate pupariation, dying as larvae with overgrown eye tissue ([Figure 2I](#fig2){ref-type="fig"}). Immunostaining using anti-β-galactosidase antibody indicated that *ex* gene expression was strongly increased in *ex*^*+/−*^,*ras1*^*G12V*^*;csk^−/−^* clones of animals raised in a control diet, demonstrating Yki activation in these clones ([Figure 2J](#fig2){ref-type="fig"}). Together these results provide compelling evidence that Ras/Src-activated cells are functionally linked to Hippo pathway activity, as even a subtle perturbation of upstream Hippo signaling is sufficient to dominantly promote tumor Ras/Src-tumor overgrowth.

Warts kinase activity is downregulated in diet-enhanced Ras/Src-tumors {#s2-4}
----------------------------------------------------------------------

To determine whether diet-enhanced Ras/Src-tumors promote Yki activity through the core Hippo signaling pathway, we performed Western-blot analysis using an antibody to the phosphorylated Serine-168 residue of Yki, a standard indication of Wts kinase activity. As anticipated, phosphorylation of Yki was significantly reduced in genotypically *wts*^*−/−*^ eye tissues. Dietary sucrose did not alter Yki phosphorylation in *lacZ*-expressing control clones ([Figure 3A](#fig3){ref-type="fig"}). In *ras1*^*G12V*^*;csk^−/−^* animals, however, HDS led to a reduction in Yki phosphorylation to a level comparable to loss of *wts* ([Figure 3A](#fig3){ref-type="fig"}). Phosphorylation was similarly reduced in eye tissues of *inr*^*CA*^*,ras1*^*G12V*^*;csk^−/−^* animals fed a control diet, indicating that increased insulin signaling is sufficient to suppress Wts kinase activity in Ras/Src-activated cells ([Figure 3A](#fig3){ref-type="fig"}). We did not observe significant changes in total Yki levels ([Figure 3A](#fig3){ref-type="fig"}). Our results indicate that (i) Ras/Src-tumors in the presence of HDS or (ii) InR/Ras/Src-tumors in a control diet promote Yki activity through inhibition of Wts kinase activity.10.7554/eLife.08501.009Figure 3.Salt-inducible Kinases are Required for Diet-enhanced Ras/Src-tumorigenesis.(**A**) Extracts from dissected eye tissues of third instar larvae were examined by immunoblotting using antibodies against phospho-Sav (p-Sav; \* indicates p-Sav specific band; the upper band is a non-specific band showed as an internal loading control), phospho-Yki (p-Yki), total Yki (Yki), and Syntaxin (Syt). (**B**, **C**) Developmental stage matched third instar larvae raised on HDS with the genotype, (**B**) *ras1*^*G12V*^;*csk^−/−^*, and (**C**) *sik2/3*^*RNAi*^*,ras1*^*G12V*^;*csk^−/−^*. (**D**, **E**) Developmental stage matched third instar larvae raised on control diet with the genotype, (**D**) *ras1*^*G12V*^;*csk^−/−^*, and (**E**) *sik2/3*^*RNAi*^*,ras1*^*G12V*^;*csk^−/−^*. Images were taken at the same magnification. Scale bar, 500 μm. (**F**, **G**) *ras1*^*G12V*^;*csk^−/−^* animals raised on HDS containing (**F**) 0.05% DMSO, or (**G**) 25 μΜ HG-9-91-01. (**H**, **I**) *inr*^*CA*^*,ras1*^*G12V*^;*csk^−/−^* animals raised on control diet containing (**H**) 0.05% DMSO, or (**I**) 25 μΜ HG-9-91-01. Images were taken at the same magnification. Scale bar, 500 μm. (**B′**--**I′**) Matching dissected eye epithelial tissue stained with DAPI (red). Images were taken at the same magnification. Scale bar, 500 μm. (**J**) Percent pupariation of DMSO or HG-9-91-01 treated animals from indicated genotypes and diets. Column bars represent the mean of three independent experiments. Error bars denote s.e.m. Total *n* of 139, 76, 123, and 72 from left to right. Asterisks indicate statistically significant difference (\*p \< 0.01 t-test). Numerical data are available in [Figure 3---source data 1](#SD3-data){ref-type="supplementary-material"}.**DOI:** [http://dx.doi.org/10.7554/eLife.08501.009](10.7554/eLife.08501.009)10.7554/eLife.08501.010Figure 3---source data 1.Percent pupariation of animals from indicated genotypes and diets.**DOI:** [http://dx.doi.org/10.7554/eLife.08501.010](10.7554/eLife.08501.010)10.7554/eLife.08501.011Figure 3---figure supplement 1.Akt mediates activation of SIKs in Ras/Src-tumors.(**A**, **B**) Developmental stage matched third instar larvae raised on HDS with the genotype, (**A**) *ras1*^*G12V*^;*csk^−/−^*, and (**B**) *ras1*^*G12V*^;*csk^−/−^*,*akt*^*hypo/hypo*^. (**C**, **D**) Developmental stage matched third instar larvae raised on control diet with the genotype, (**C**) *inr*^*CA*^*,ras1*^*G12V*^;*csk^−/−^*, and (**D**) *inr*^*CA*^*,ras1*^*G12V*^;*csk^−/−^*,*akt*^*hypo/hypo*^. Images were taken at the same magnification. Scale bar, 500 μm. (**A′**--**D′**) Matching dissected eye epithelial tissue stained with DAPI (red). Images were taken at the same magnification. Scale bar, 500 μm. (**E**) Extracts from dissected eye tissues of third instar larvae were examined by immunoblotting using antibodies against phospho-Sav (p-Sav; \* indicates p-Sav specific band; the upper band is a non-specific band showed as an internal loading control) and Syntaxin (Syt).**DOI:** [http://dx.doi.org/10.7554/eLife.08501.011](10.7554/eLife.08501.011)10.7554/eLife.08501.012Figure 3---figure supplement 2.Reducing SIK2/3 by RNAi did not affect normal eye tissue growth.(**A**, **B**) Developmental stage matched third instar larvae raised on HDS with genotypes, (**A**) *lacZ*, and (**B**) *sik2/3*^*RNAi*^. Images were taken at the same magnification. Scale bar, 500 μm. (**A′**, **B′**) Matching dissected eye epithelial tissue stained with DAPI (red). Images were taken at the same magnification. Scale bar, 500 μm.**DOI:** [http://dx.doi.org/10.7554/eLife.08501.012](10.7554/eLife.08501.012)

Salt-inducible kinases mediate diet-enhanced ras/src-tumor overgrowth {#s2-5}
---------------------------------------------------------------------

Salt-inducible kinases (SIKs) were recently shown to regulate wing tissue growth through Hippo pathway activity in *Drosophila* ([@bib31]). Phosphorylation of Salvador (Sav) at Serine-413 by SIK led to dissociation of the Hippo complex and activation of Yki ([@bib31]). In the eye tissue of *ras1*^*G12V*^*;csk^−/−^* larvae fed HDS, Serine-413 phosphorylation of Sav was strongly upregulated ([Figure 3A](#fig3){ref-type="fig"}). Similarly, phosphorylation of Sav was strongly elevated in *inr*^*CA*^*,ras1*^*G12V*^*;csk^−/−^* animals fed a control diet, demonstrating that increased insulin signaling in Ras/Src-activated cells promotes SIK activity ([Figure 3A](#fig3){ref-type="fig"}).

Previous studies in mammals and *Drosophila* have shown that SIKs are activated by Akt ([@bib7]; [@bib30]; [@bib5]). Reducing Akt activity through a hypomorphic allele of *akt* (*ras1*^*G12V*^*;csk^−/−^,akt*^*hypo/hypo*^) suppressed Ras/Src-tumor growth and reduced phosphorylation of Sav in animals raised on HDS ([Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}). Similarly, tumor growth and phosphorylation of Sav was suppressed in *inr*^*CA*^*,ras1*^*G12V*^*;csk^−/−^,akt*^*hypo/hypo*^ animals fed a control diet ([Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}). These results demonstrate that---in *ras1*^*G12V*^*;csk^−/−^* larval eye tissue fed HDS and *inr*^*CA*^*,ras1*^*G12V*^*;csk^−/−^* animals fed a control diet---activation of SIKs are mediated by Akt.

To examine whether the SIKs are required for diet-enhanced Ras/Src-tumorigenesis, we used a transgenic RNA-interference line that targets both *sik2* and *sik3* transcripts for knockdown ([@bib31]). Reducing SIK2/3 in *ras1*^*G12V*^*;csk^−/−^* animals (*sik2*^*RNAi*^*,ras1*^*G12V*^*;csk^−/−^*) suppressed diet-enhanced Ras/Src-tumor growth ([Figure 3B,C](#fig3){ref-type="fig"}). Importantly, reducing SIK2/3 by itself did not significantly affect normal eye tissue growth of animals fed HDS ([Figure 3---figure supplement 2](#fig3s2){ref-type="fig"}), indicating that SIK2/3 is functionally required for Ras/Src-tumor growth in the presence of HDS. Feeding HG-9-91-01, a potent inhibitor of SIKs ([@bib6]), led to suppression of tumor growth and animal lethality in both *ras1*^*G12V*^*;csk^−/−^* animals fed HDS and in *inr*^*CA*^*,ras1*^*G12V*^*;csk^−/−^* animals fed a control diet ([Figure 3F-J](#fig3){ref-type="fig"}). We conclude that activation of SIKs is functionally required for diet-enhanced Ras/Src-tumorigenesis.

Conversely, expression of a constitutive active isoform of SIK2 (*sik2*^*CA*^ ([@bib31])) in Ras/Src-activated cells (*ras1*^*G12V*^*;csk^−/−^,sik2*^*CA*^) was sufficient to promote Ras/Src-dependent tumor overgrowth even in a control diet ([Figure 4A,B](#fig4){ref-type="fig"}). Western blot analysis confirmed increased phosphorylation of Sav and reduced phosphorylation of Yki in *ras1*^*G12V*^*;csk^−/−^,sik2*^*CA*^ tumors ([Figure 4C](#fig4){ref-type="fig"}). Wg expression was strongly upregulated in *ras1*^*G12V*^*;csk^−/−^,sik2*^*CA*^ tumors in animals raised on a control diet ([Figure 4D,E](#fig4){ref-type="fig"}), further linking SIKs to Hippo pathway activity. Taken together, these results demonstrate that SIKs provide the upstream Hippo signal that mediates Ras/Src-tumorigenesis in diet-induced obese animals.10.7554/eLife.08501.013Figure 4.Activation of Salt-inducible Kinase Promotes Ras/Src-tumor Growth.(**A**, **B**) Developmental stage matched third instar larvae raised on control diet with the genotype, (**A**) *ras1*^*G12V*^;*csk^−/−^*, and (**B**) *ras1*^*G12V*^*;csk^−/−^,sik2*^*CA*^. Images were taken at the same magnification. Scale bar, 500 μm. (**A′**, **B′**) Matching dissected eye epithelial tissue stained with DAPI (red). Images were taken at the same magnification. Scale bar, 500 μm. (**C**) Extracts from dissected eye tissues of *ras1*^*G12V*^*;csk^−/−^* and *ras1*^*G12V*^*;csk^−/−^,sik2*^*CA*^ animals fed a control diet were examined by immunoblotting using antibodies against phospho-Sav (p-Sav; \* indicates p-Sav specific band; the upper band is a non-specific band showed as an internal loading control), phospho-Yki (p-Yki), total Yki (Yki), and Syntaxin (Syt). (**D**, **E**) Wg staining (red) of eye tissue from (**D**) *ras1*^*G12V*^*;csk^−/−^*, and (**E**) *ras1*^*G12V*^*;csk^−/−^,sik2*^*CA*^ animals raised on control diet. Scale bars, 50 μm. (**F**) Model of diet-enhanced tumorigenesis of Ras/Src-activated cells.**DOI:** [http://dx.doi.org/10.7554/eLife.08501.013](10.7554/eLife.08501.013)

Discussion {#s3}
==========

We previously demonstrated that Ras/Src-activated cells preserve mitogenic effects of insulin under the systemic insulin resistance induced by HDS-feeding of *Drosophila* ([@bib15]). Evasion of insulin resistance in Ras/Src-activated cells is a consequence of a Wg-dependent increase in InR gene expression ([@bib15]). In this study, we identify the Hippo pathway effector Yki as a primary source of the Wnt ortholog Wg in diet-enhanced Ras/Src-tumors. Mechanistically, we provide functional evidence that activation of SIKs promotes Yki-dependent Wg-activation and reveal a SIK-Yki-Wg-InR axis as a key feed-forward signaling pathway that underlies evasion of insulin resistance and promotion of tumor growth in diet-enhanced Ras/Src-tumors ([Figure 4F](#fig4){ref-type="fig"}).

In animals fed a control diet, we observed at most a mild increase in Yki reporter activity within *ras1*^*G12V*^*;csk^−/−^* cells ([Figure 2A](#fig2){ref-type="fig"}). A previous report indicates that activation of oncogenic Ras (*ras1*^*G12V*^) led to slight activation of Yki in eye tissue ([@bib24]; [@bib9]; [@bib10]). Activation of Src through over-expression of the *Drosophila* Src ortholog Src64B has been shown to induce autonomous and non-autonomous activation of Yki ([@bib9]). In contrast, inducing activation of Src through loss of *csk* (*csk^−/−^*) failed to elevate *diap1* expression (data not shown). Our results indicate that activation of Yki is an emergent property of activating Ras plus Src (*ras1*^*G12V*^*;csk^−/−^*). However, this level of Yki-activation was not sufficient to promote stable tumor growth of Ras/Src-activated cells in the context of a control diet: Ras/Src-activated cells were progressively eliminated from the eye tissue ([@bib15]). It was, however, sufficient to sensitize Ras/Src-activated cells to upstream Hippo pathway signals: loss of a genetic copy of *ex*---which was not sufficient to promote growth by itself---dominantly promoted tumor growth of Ras/Src-activated cells even in animals fed a control diet ([Figure 2G-I](#fig2){ref-type="fig"}). These data provide compelling evidence that Ras/Src-transformed cells are sensitive to upstream Hippo signals.

SIK was recently demonstrated to phosphorylate Sav at Serine-413, resulting in dissociation of the Hippo complex and activation of Yki ([@bib31]). SIKs are required for diet-enhanced Ras/Src-tumor growth in HDS ([Figure 3C](#fig3){ref-type="fig"}). Conversely, expression of a constitutively activated isoform of SIK was sufficient to promote Ras/Src-tumor overgrowth even in a control diet ([Figure 4B](#fig4){ref-type="fig"}). Mammalian SIKs are regulated by glucose and by insulin signaling ([@bib29], [@bib30]). However, a more recent report indicated that glucagon but not insulin regulates SIK2 activity in the liver ([@bib25]). Our data demonstrate that increased insulin signaling is sufficient to promote SIK activity through Akt in Ras/Src-activated cells ([Figure 3A](#fig3){ref-type="fig"}, [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}). We conclude that SIKs couple nutrient (insulin) availability to Yki-mediated evasion of insulin resistance and tumor growth, ensuring Ras/Src-tumor growth under nutrient favorable conditions.

Our results place SIKs as key sensors of nutrient and energy availability in Ras/Src-tumors through increased insulin signaling and, hence, increased glucose availability. SIK activity promotes Ras/Src-activated cells to efficiently respond to upstream Hippo signals, ensuring tumor overgrowth in organisms that are otherwise insulin resistant. One interesting question is whether this mechanism is relevant beyond the context of an obesity-cancer connection: both Ras and Src have pleiotropic effects on developmental processes including survival, proliferation, morphogenesis, differentiation, and invasion, and these mechanisms may facilitate these processes under nutrient favorable conditions. From a treatment perspective our data highlight SIKs as potential therapeutic targets. Limiting SIK activity through compounds such as HG-9-91-01 may break the connection between oncogenes and diet, targeting key aspects of tumor progression that are enhanced in obese individuals.

Materials and methods {#s4}
=====================

Fly stocks {#s4-1}
----------

*UAS-ras1*^*G12V*^*, UAS-inr*^*A1325D*^ *(inr*^*CA*^*), UAS-wts, ex*^*697*^*(ex-lacZ) , Diap1*^*j5C8*^ *(diap1-lacZ), akt*^*04226*^ flies were obtained from the Bloomington *Drosophila* Stock Center. *UAS-wg*^*RNAi*^ and *UAS-sik2*^*RNAi*^ flies were obtained from Vienna *Drosophila* RNAi Center. The following stocks were kindly provided to us: *FRT82B, csk*^*Q156Stop*^ by A. O\'Reilly and M. Simon; *ey(3.5)-FLP1* by G. Halder; *UAS-sik2*^*S1032A*^ (*sik2*^*CA*^) by N. Tapon; *wts*^*X1*^ by C. Pfleger.

To create eyeless-driven green fluorescent protein (GFP)--labeled clones, flies with the genotype *ey(3.5)-FLP1; act \> y+\>gal4,UAS-GFP; FRT82B,tub-gal80* were crossed with flies with the following genotypes: (a) *UAS-ras1*^*G12V*^*; FRT82B, csk*^*Q156Stop*^*/TM6b*; (b) *UAS-ras1*^*G12V*^*; FRT82B, csk*^*Q156Stop*^*, UAS-wg*^*RNAi*^*/TM6b*; (c) *UAS-ras1*^*G12V*^*; FRT82B, csk*^*Q156Stop*^*, UAS-wts/TM6b*; (d) *UAS-inr*^*A1325D*^*, UAS-ras1*^*G12V*^*; FRT82B, csk*^*Q156Stop*^*/TM6b*; (e) *UAS-inr*^*A1325D*^*, UAS-ras1*^*G12V*^*; FRT82B, csk*^*Q156Stop*^*, UAS-wg*^*RNAi*^*/TM6b*; (f) *UAS-inr*^*A1325D*^*, UAS-ras1*^*G12V*^*; FRT82B, csk*^*Q156Stop*^*, UAS-wts/TM6b*; (g) *FRT82B, UAS-wg*^*RNAi*^; (h) *FRT82B, UAS-wts*; (i) *UAS-ras1*^*G12V*^*; diap1-lacZ, FRT82B, csk*^*Q156Stop*^*/TM6b*; (j) *UAS-inr*^*A1325D*^*, UAS-ras1*^*G12V*^*; diap1-lacZ, FRT82B, csk*^*Q156Stop*^*/TM6b*; (k) *UAS-inr*^*A1325D*^*; diap1-lacZ, FRT82B/TM6b*; (l) *ex*^*697*^*; FRT82B/SM6-TM6b*; (m) *ex*^*697*^*, UAS-ras1*^*G12V*^*; FRT82B, csk*^*Q156Stop*^*/SM6-TM6b*; (n) *FRT82B, wts*^*X1*^*/TM6b*; (o) *UAS-lacZ; FRT82B*; (p) *UAS-sik2*^*RNAi*^*, UAS-ras1*^*G12V*^*; FRT82B, csk*^*Q156Stop*^*/TM6b*; (q) *UAS-ras1*^*G12V*^*; UAS-sik2*^*CA*^*, FRT82B, csk*^*Q156Stop*^*/TM6b*; (r) *UAS-sik2*^*RNAi*^*; FRT82B*; (s) *UAS-ras1*^*G12V*^*; FRT82B, csk*^*Q156Stop*^*, akt*^*04226*^ */TM6b*; (t) *UAS-inr*^*A1325D*^*, UAS-ras1*^*G12V*^*; FRT82B, csk*^*Q156Stop*^*, akt*^*04226*^ */TM6b*.

Cultures {#s4-2}
--------

Cultures were carried out on Bloomington semi-defined medium (described by the Bloomington *Drosophila* stock center) with modifications. Detailed recipes for control diet and HDS is previously described ([@bib18]). The following final concentrations of carbohydrates were included: 0.15 M sucrose (control diet) and 1.0 M sucrose (HDS). Cultures were performed at 25°C.

Immunofluorescence, western blotting {#s4-3}
------------------------------------

These procedures were performed as previously described ([@bib15]). Primary antibodies used for immunofluorescence were: mouse anti-Wingless (DSHB: Developmental Studies Hybridoma Bank, Iowa City, IA, United States), mouse anti-Cyclin E (DSHB), mouse anti-β-galactosidase (DSHB), rabbit anti-Myc (Santa Cruz Biotechnology, Dallas, TX, United States). Western blots were probed with antibodies against Yki (gift from K Irvine) ([@bib23]), phospho-Yki (pS168) (gift from D. *Pan*) ([@bib8]), phospho-Sav (pS413) (gift from N Tapon) ([@bib31]), and Syntaxin (DSHB).

Drugs {#s4-4}
-----

HG-9-91-01 (MedChem Express, Princeton, NJ, United States) was solubilized in DMSO and diluted directly into the fly medium and vortexed extensively to obtain a homogeneous culture.
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Thank you for submitting your work entitled "Salt-Inducible Kinases Mediate Nutrient-Sensing To Link Dietary Sugar and Tumorigenesis in *Drosophila"* for peer review at *eLife*. Your submission has been favorably evaluated by Tony Hunter (Senior Editor) and two reviewers, one of whom is a member of our Board of Reviewing Editors.

The reviewers have discussed the reviews with one another and the Reviewing editor has drafted this decision to help you prepare a revised submission.

The work addresses the link between diabetes/obesity and increased tumour susceptibility. In previous work, the authors have established a *Drosophila* model in which a combination of dietary glucose and Ras + Src oncogenes can lead to enhanced tumorigenesis by inducing the expression of Wnt and Insulin Receptor. In the current manuscript, the authors identify the Hippo pathway effector Yorkie as an essential mediator of Wnt induction in the tumors. Mechanistically, the authors show that activation of Yki is due to activation of Salt Inducible Kinases (SIKs) by Ras + Src + dietary glucose. Overall, the study is well conducted and clearly presented, and will be of broad interest to the cancer, diabetes and developmental growth control communities. The authors have identified a potentially important mechanism by which nutrients cooperate oncogenes to drive tumorigenesis. Furthermore, this represents the first clear demonstration that the Hippo pathway is regulated by metabolism.

Essential revisions:

1\) Some additional insight into how SIK is activated in response to HDS would strengthen the study. Is it Akt-dependent, as is suggested by the strong activation of Akt by HDS in their previous study (Hirabayashi et al., Cell 2013)? This could be addressed by activating Akt in normal diet or RNAi depletion of Akt in HDS.

2\) Please include statistics (Reviewer 1), the molecular weight markers and scale bars (Reviewer 2) in the revision.
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Essential revisions:

1\) Some additional insight into how SIK is activated in response to HDS would strengthen the study. Is it Akt-dependent, as is suggested by the strong activation of Akt by HDS in their previous study (Hirabayashi et al., Cell 2013)? This could be addressed by activating Akt in normal diet or RNAi depletion of Akt in HDS.

Previous studies in mammals and *Drosophila* have shown that SIKs are activated by Akt. To assess the role of Akt in activation of SIKs in our model, we used a hypomorphic allele of *akt* (*akt*^*04226*^) and established *ras1*^*G12V*^*;csk*^*−/−*^,*akt*^*hypo/hypo*^ and *inr*^*CA*^*,ras1*^*G12V*^*;csk*^*−/−*^,*akt*^*hypo/hypo*^ lines. Reducing Akt-activity in *ras1*^*G12V*^*;csk*^*−/−*^ animals raised on a HDS or in *inr*^*CA*^*,ras1*^*G12V*^*;csk*^*−/−*^ animals raised on a control diet both suppressed tumor growth and activation of SIKs as assessed by Western-blot analysis using anti-phospho Sav antibody ([Figure 3--figure supplement 1](#fig3s1){ref-type="fig"}). Therefore, together with the evidence that increased insulin signaling in Ras/Src-activated cells (*inr*^*CA*^*,ras1*^*G12V*^*;csk*^*−/−*^) promotes SIK activity ([Figure 3A](#fig3){ref-type="fig"}), we now clearly demonstrate that the activation of SIKs in the eye tissues of *ras1*^*G12V*^*;csk*^*−/−*^ larvae fed HDS and in *inr*^*CA*^*, ras1*^*G12V*^*;csk*^*−/−*^ animals fed a control diet are mediated by Akt.

2\) Please include statistics (Reviewer 1), the molecular weight markers and scale bars (Reviewer 2) in the revision.

We have provided statistics for the quantification in [Figures 1H, 2I and 3J](#fig1 fig2 fig3){ref-type="fig"}, molecular weight markers in all Western-blot data and scale bars in all immunofluorescence data.
